calcium acetate has been researched along with Hyperphosphatemia in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (3.03) | 18.2507 |
| 2000's | 8 (24.24) | 29.6817 |
| 2010's | 21 (63.64) | 24.3611 |
| 2020's | 3 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Araujo, R; Bancu, I; Bonal, J; Graterol, F; Merino-Ribas, A; Noguera-Julian, M; Paredes, R; Sampaio-Maia, B; Vergara, A | 1 |
| Berner, T; Dieguez, G; Ferro, C; Kovesdy, CP; Metz, S; Moore, J; Szabo, E | 1 |
| Block, GA; Chertow, GM; Chonchol, M; de Boer, IH; Ginsberg, C; Hoofnagle, A; Kestenbaum, B; Zelnick, LR | 1 |
| Huynh, T; Nguyen, T; Pham, T | 1 |
| Behets, GJ; D'Haese, PC; De Schutter, TM; Geryl, H; Gundlach, K; Neven, E; Passlick-Deetjen, J; Peter, ME; Steppan, S | 1 |
| Büschges-Seraphin, B; Covic, A; de Francisco, AL; Ghenu, A; Kroczak, M; Marzell, B; Passlick-Deetjen, J; Ponce, P | 1 |
| Chatterley, T; Dorgan, M; Fitchett, D; Jamal, SA; Lok, CE; Mendelssohn, DC; Raggi, P; Tsuyuki, RT; Vandermeer, B | 1 |
| Bennett-Jones, D; Dasgupta, I; McVeigh, G; Shroff, R | 1 |
| St Peter, WL; Weinhandl, ED; Yusuf, AA | 1 |
| Galani, VJ; Prajapati, VA; Shah, PR | 1 |
| Albines, Z; Arias, M; Belmar, L; de Francisco, AL; Kislikova, M; Piñera, C; Sango, C; Seras, M; Serrano, M | 1 |
| Huang, Y; Mao, Z; Wang, Y; Xie, G; Yang, B; Zhang, H | 1 |
| Abraham, JD; Arfeen, SS; Bowline, IG; Chernin, G; Dwyer, JP; Fadem, SZ; Goral, S; Greene, T; Koury, M; Lewis, JB; Middleton, J; Sika, M; Sinsakul, MV; Umanath, K; Van Buren, PN; Weiner, DE | 1 |
| Copland, M; Komenda, P; McCullough, PA; Morfin, JA; Weinhandl, ED | 1 |
| Caputo, F; Chasan-Taber, S; Duggal, A; Evenepoel, P; Fan, S; Foggensteiner, L; Heaf, JG; Kelly, A; Ortiz, A; Selgas, R | 1 |
| Bleyer, AJ | 1 |
| Hutchison, AJ; Mohammed, I | 1 |
| Shigematsu, T; Skaguchi, T | 1 |
| Craig, JC; Elder, GJ; Navaneethan, SD; Palmer, SC; Strippoli, GF | 1 |
| Fan, Q; Liu, J; St Peter, WL; Weinhandl, E | 2 |
| Assimon, MM; Mousa, S; Pai, AB; Shaker, O | 1 |
| Benedyk-Lorens, E; Covic, AC; de Francisco, AL; Ketteler, M; Leidig, M; Mircescu, GM; Passlick-Deetjen, J; Ponce, P; Scholz, C | 1 |
| Chen, YM; Chiang, WC; Chu, TS; Huang, CY; Huang, JW; Hung, KY; Kan, WC; Kao, TW; Lin, SL; Lin, YF; Tsai, TJ; Wu, KD; Wu, MS; Yen, CJ | 1 |
| Kestenbaum, B; Liu, J; Winkelmayer, WC | 1 |
| Brenchley, PE; Hutchison, AJ; Smith, CP | 1 |
| Caglar, K; Eyileten, T; Kilic, S; Mallamaci, F; Oguz, Y; Saglam, M; Sonmez, A; Vural, A; Yaman, H; Yenicesu, M; Yilmaz, MI; Zoccali, C | 1 |
| Drüeke, TB; Massy, ZA | 1 |
| Allison, MA; Asplin, J; Block, GA; Chertow, GM; Hoofnagle, AN; Kestenbaum, B; Ketteler, M; Kooienga, L; Mannstadt, M; Persky, MS; Smits, G; Spiegel, DM; Thadhani, R; Wheeler, DC; Wolf, M | 1 |
| Evenepoel, P; Meijers, B | 1 |
| Bernard, LM; Dunn, ES; Grima, DT; Mendelssohn, DC | 1 |
| Binswanger, U; Hess, B | 1 |
| Tonelli, M; Winkelmayer, WC | 1 |
9 review(s) available for calcium acetate and Hyperphosphatemia
| Article | Year |
|---|---|
Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis.
Topics: Acetates; Aged; Calcium Carbonate; Calcium Compounds; Cause of Death; Chelating Agents; Female; Humans; Hyperphosphatemia; Male; Middle Aged; Phosphates; Randomized Controlled Trials as Topic; Renal Dialysis; Renal Insufficiency, Chronic | 2013 |
Management of hyperphosphataemia in chronic kidney disease: summary of National Institute for Health and Clinical Excellence (NICE) guideline.
Topics: Acetates; Calcium Carbonate; Calcium Compounds; Chelating Agents; Chelation Therapy; Diet Therapy; Evidence-Based Medicine; Humans; Hyperphosphatemia; Nephrology; Practice Guidelines as Topic; Renal Dialysis; Renal Insufficiency, Chronic; United States | 2013 |
Calcium acetate or calcium carbonate for hyperphosphatemia of hemodialysis patients: a meta-analysis.
Topics: Acetates; Adult; Calcium Carbonate; Calcium Compounds; Female; Humans; Hyperphosphatemia; Male; Renal Dialysis | 2015 |
Intensive Hemodialysis, Mineral and Bone Disorder, and Phosphate Binder Use.
Topics: Acetates; Bone Diseases; Calcium Compounds; Chelating Agents; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Phosphates; Renal Dialysis; Sevelamer | 2016 |
Oral phosphate binders for the management of serum phosphate levels in dialysis patients.
Topics: Acetates; Administration, Oral; Aluminum Hydroxide; Calcium Carbonate; Calcium Compounds; Cardiovascular Diseases; Chelating Agents; Drug Monitoring; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Kidney Failure, Chronic; Lanthanum; Magnesium; Nephrology; Patient Education as Topic; Phosphorus; Polyamines; Practice Guidelines as Topic; Renal Dialysis; Sevelamer; Treatment Outcome | 2009 |
[Clinical aspect of recent progress in phosphate metabolism. Management of hyperphosphagtemia].
Topics: Acetates; Aluminum Hydroxide; Calcium Carbonate; Calcium Compounds; Chelating Agents; Drug Design; Gels; Humans; Hyperphosphatemia; Lanthanum; Macromolecular Substances; Phosphorus, Dietary; Polyamines; Polymers; Renal Dialysis; Sevelamer | 2009 |
Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trials.
Topics: Acetates; Biomarkers; Bone Density Conservation Agents; Calcium; Calcium Carbonate; Calcium Compounds; Chelating Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Hypercalcemia; Hyperphosphatemia; Lanthanum; Parathyroid Hormone; Phosphates; Phosphorus; Polyamines; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic; Research Design; Sevelamer | 2009 |
The effect of sevelamer hydrochloride and calcium-based phosphate binders on mortality in hemodialysis patients: a need for more research.
Topics: Acetates; Calcium Carbonate; Calcium Compounds; Cardiovascular Diseases; Chelating Agents; Clinical Trials as Topic; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Polyamines; Renal Dialysis; Sevelamer | 2010 |
Pharmacology, efficacy and safety of oral phosphate binders.
Topics: Acetates; Animals; Calcium Compounds; Chelating Agents; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperphosphatemia; Intestinal Absorption; Kidney Failure, Chronic; Kidney Tubules, Proximal; Lanthanum; Parathyroid Hormone; Phosphates; Polyamines; Renal Dialysis; Sevelamer | 2011 |
11 trial(s) available for calcium acetate and Hyperphosphatemia
| Article | Year |
|---|---|
Gut microbiome in hemodialysis patients treated with calcium acetate or treated with sucroferric oxyhydroxide: a pilot study.
Topics: Acetates; Calcium Compounds; Drug Combinations; Ferric Compounds; Gastrointestinal Microbiome; Humans; Hyperphosphatemia; Pilot Projects; Renal Dialysis; RNA, Ribosomal, 16S; Sucrose | 2022 |
Differential effects of phosphate binders on vitamin D metabolism in chronic kidney disease.
Topics: Acetates; Aged; Calcium Compounds; Chelating Agents; Double-Blind Method; Female; Humans; Hyperphosphatemia; Lanthanum; Male; Middle Aged; Phosphates; Prognosis; Renal Insufficiency, Chronic; Sevelamer; Vitamin D | 2020 |
A comparison of calcium acetate/magnesium carbonate and sevelamer-hydrochloride effects on fibroblast growth factor-23 and bone markers: post hoc evaluation from a controlled, randomized study.
Topics: Acetates; Adolescent; Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Biomarkers; Bone and Bones; Calcium Compounds; Chelating Agents; Enzyme-Linked Immunosorbent Assay; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Follow-Up Studies; Glomerular Filtration Rate; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Kidney Function Tests; Magnesium; Male; Middle Aged; Parathyroid Hormone; Polyamines; Prognosis; Renal Dialysis; Risk Factors; Sevelamer; Young Adult | 2013 |
The Phosphate Binder Ferric Citrate and Mineral Metabolism and Inflammatory Markers in Maintenance Dialysis Patients: Results From Prespecified Analyses of a Randomized Clinical Trial.
Topics: Acetates; Aged; Calcium; Calcium Compounds; Chelating Agents; Female; Ferric Compounds; Humans; Hyperphosphatemia; Inflammation Mediators; Kidney Failure, Chronic; Male; Middle Aged; Phosphates; Polyamines; Renal Dialysis; Sevelamer | 2015 |
Efficacy and safety of sevelamer hydrochloride and calcium acetate in patients on peritoneal dialysis.
Topics: Acetates; Adult; Aged; Calcium Compounds; Chelating Agents; Drug Tolerance; Female; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis; Phosphorus; Polyamines; Sevelamer | 2009 |
Economic evaluation of sevelamer versus calcium-based phosphate binders in hemodialysis patients: a secondary analysis using centers for Medicare & Medicaid services data.
Topics: Acetates; Calcium Carbonate; Calcium Compounds; Chelating Agents; Cost-Benefit Analysis; Drug Costs; Follow-Up Studies; Health Care Costs; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Medicaid; Medicare; Phosphates; Polyamines; Renal Dialysis; Sevelamer; Treatment Outcome; United States | 2009 |
Evaluation of calcium acetate/magnesium carbonate as a phosphate binder compared with sevelamer hydrochloride in haemodialysis patients: a controlled randomized study (CALMAG study) assessing efficacy and tolerability.
Topics: Acetates; Adolescent; Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Calcium Compounds; Female; Humans; Hyperphosphatemia; Magnesium; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Polyamines; Renal Dialysis; Sevelamer | 2010 |
Benefits of sevelamer on markers of bone turnover in Taiwanese hemodialysis patients.
Topics: Acetates; Adult; Aged; Alkaline Phosphatase; Asian People; Biomarkers; Bone Remodeling; Calcium Compounds; Calcium Phosphates; Chelating Agents; Female; Humans; Hypercalcemia; Hyperphosphatemia; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Phosphorus Metabolism Disorders; Polyamines; Prospective Studies; Renal Dialysis; Sevelamer; Treatment Outcome | 2010 |
Comparison of calcium acetate and sevelamer on vascular function and fibroblast growth factor 23 in CKD patients: a randomized clinical trial.
Topics: Acetates; Adult; Calcium Compounds; Chelating Agents; Chronic Disease; Comorbidity; Endothelium, Vascular; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Forearm; Humans; Hyperphosphatemia; Kidney Diseases; Middle Aged; Phosphates; Polyamines; Prospective Studies; Regional Blood Flow; Sevelamer; Severity of Illness Index; Treatment Outcome; Vasodilation | 2012 |
Effects of phosphate binders in moderate CKD.
Topics: Acetates; Aged; Aged, 80 and over; Bone Density; Calcium Compounds; Chelating Agents; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperphosphatemia; Lanthanum; Male; Middle Aged; Parathyroid Hormone; Phosphates; Pilot Projects; Polyamines; Renal Insufficiency, Chronic; Sevelamer; Vascular Calcification | 2012 |
A comparison of sevelamer and calcium-based phosphate binders on mortality, hospitalization, and morbidity in hemodialysis: a secondary analysis of the Dialysis Clinical Outcomes Revisited (DCOR) randomized trial using claims data.
Topics: Acetates; Aged; Calcium Compounds; Chelating Agents; Female; Hemodialysis Solutions; Hospitalization; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Male; Middle Aged; Polyamines; Renal Dialysis; Sevelamer | 2008 |
13 other study(ies) available for calcium acetate and Hyperphosphatemia
| Article | Year |
|---|---|
Real-World Phosphate Binder Use among Dialysis-Dependent Patients with CKD.
Topics: Aged; Chelating Agents; Ferric Compounds; Humans; Hyperphosphatemia; Medicare; Phosphates; Renal Dialysis; Renal Insufficiency, Chronic; Sevelamer; United States | 2023 |
Phosphate binder choices used in ESRD patients.
Topics: Acetates; Adult; Aged; Aged, 80 and over; Calcium Compounds; Chelating Agents; Female; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Male; Middle Aged; Phosphates; Retrospective Studies; Sevelamer; Young Adult | 2016 |
Effect of a magnesium-based phosphate binder on medial calcification in a rat model of uremia.
Topics: Acetates; Adenine; Animals; Aortic Diseases; Bone Morphogenetic Protein 2; Calcium; Calcium Compounds; Calcium-Binding Proteins; Chelating Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Extracellular Matrix Proteins; Gene Expression Regulation; Hyperphosphatemia; Kidney Failure, Chronic; Magnesium; Male; Matrix Gla Protein; Parathyroid Hormone; Phosphates; Polyamines; Rats; Rats, Wistar; Sevelamer; SOX9 Transcription Factor; Time Factors; Uremia; Vascular Calcification | 2013 |
Comparative effectiveness of calcium acetate and sevelamer on clinical outcomes in elderly hemodialysis patients enrolled in Medicare part D.
Topics: Acetates; Aged; Aged, 80 and over; Calcium Compounds; Female; Humans; Hyperphosphatemia; Kaplan-Meier Estimate; Kidney Failure, Chronic; Male; Medicare Part D; Polyamines; Renal Dialysis; Sevelamer; Survival Rate; Treatment Outcome; United States | 2014 |
A comparative study of phosphate binders in patients with end stage kidney disease undergoing hemodialysis.
Topics: Acetates; Adult; Biomarkers; Calcium; Calcium Carbonate; Calcium Compounds; Chelating Agents; Female; Humans; Hypercalcemia; Hyperphosphatemia; Kidney Failure, Chronic; Lanthanum; Male; Middle Aged; Phosphorus; Polyamines; Renal Dialysis; Retrospective Studies; Sevelamer; Time Factors; Treatment Outcome | 2014 |
Effect of calcium acetate/magnesium carbonate in the treatment of hyperphosphataemia in dialysis patients in real clinical practice. One year follow up.
Topics: Acetates; Calcium Compounds; Female; Follow-Up Studies; Humans; Hyperphosphatemia; Magnesium; Male; Middle Aged; Prospective Studies; Renal Dialysis; Time Factors; Treatment Outcome | 2014 |
Hyperphosphatemia in the Calcium Acetate Renagel Evaluation-2 (CARE-2) Study.
Topics: Acetates; Calcium Compounds; Chelating Agents; Humans; Hyperphosphatemia; Polyamines; Sevelamer | 2008 |
Comparative effectiveness of calcium-containing phosphate binders in incident U.S. dialysis patients.
Topics: Acetates; Adult; Aged; Calcium Carbonate; Calcium Compounds; Cohort Studies; Female; Humans; Hyperphosphatemia; Male; Middle Aged; Prospective Studies; Renal Dialysis | 2011 |
Phosphate binders in CKD: bad news or good news?
Topics: Acetates; Calcium Compounds; Chelating Agents; Female; Humans; Hyperphosphatemia; Lanthanum; Male; Polyamines; Renal Insufficiency, Chronic; Sevelamer | 2012 |
Chronic kidney disease: Phosphate binder therapy--cracks in the tower of strength?
Topics: Acetates; Blood Vessels; Calcinosis; Calcium Compounds; Chelating Agents; Disease Progression; Humans; Hyperphosphatemia; Lanthanum; Phosphate-Binding Proteins; Phosphates; Polyamines; Renal Insufficiency, Chronic; Sevelamer | 2012 |
Impact of sevelamer versus calcium-based binders on hospitalizations and missed in-center dialysis treatments among CKD patients on dialysis: a modeled analysis.
Topics: Acetates; Calcium Compounds; Chelating Agents; Confidence Intervals; Female; Hospitalization; Humans; Hyperphosphatemia; Male; Markov Chains; Middle Aged; Outcome Assessment, Health Care; Patient Compliance; Polyamines; Renal Dialysis; Renal Insufficiency, Chronic; Sevelamer | 2013 |
Long-term administration of calcium acetate efficiently controls severe hyperphosphataemia in haemodialysis patients.
Topics: Acetates; Adult; Calcium; Calcium Compounds; Female; Humans; Hypercalcemia; Hyperphosphatemia; Kidney Diseases; Male; Middle Aged; Phosphates; Renal Dialysis; Young Adult | 1990 |
Phosphate binder choice in dialysis patients: a call for evidence-based rather than marketing-based clinical practice.
Topics: Acetates; Calcium Compounds; Chelating Agents; Hemodialysis Solutions; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Nephrology; Polyamines; Practice Patterns, Physicians'; Renal Dialysis; Research Design; Sevelamer | 2008 |